BioNTech SE (FRA:22UA)
Germany · Delayed Price · Currency is EUR 84.80
-0.75 (-0.88%)
At close: Sep 18, 2026
BioNTech SE Employees
BioNTech SE had 7,807 employees as of December 31, 2025. The number of employees increased by 1,035 or 15.28% compared to the previous year.
Employees
7,807
Change (1Y)
1,035
Growth (1Y)
15.28%
Revenue / Employee
€339,439
Profits / Employee
€216,011
Market Cap
21.04B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,807 | 1,035 | 15.28% |
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 178,486 |
| Fresenius Medical Care AG | 107,226 |
| Bayer Aktiengesellschaft | 87,830 |
| Siemens Healthineers AG | 74,300 |
| Merck KGaA | 62,136 |
| Fielmann Group AG | 18,928 |
| Sartorius Aktiengesellschaft | 14,279 |
| Ottobock SE & Co. KGaA | 9,406 |
BioNTech SE News
- 3 days ago - Health Canada authorizes Pfizer, BioNTech’s Omicron XFG-adapted Covid-19 vaccine - TheFly
- 4 days ago - BioNTech price target raised to $140 from $132 at Berenberg - TheFly
- 6 days ago - BioNTech, OncoC4 announce first median overall survival data from PRESERVE-003 - TheFly
- 6 days ago - BioNTech says lung cancer drug candidate prolonged lives in trial - Reuters
- 6 days ago - BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients - GlobeNewsWire
- 12 days ago - BioNTech downgraded to Market Perform from Outperform at BMO Capital - TheFly
- 20 days ago - BioNTech price target lowered to $136 from $142 at Canaccord - TheFly
- 23 days ago - BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why - TipRanks